In addition to exerting E2-like effects, studies with ER-positive breast cancer cells show BPA antagonizes the proapoptotic effects of tamoxifen while favoring transition of cell cycle from G1 to S phase, and upregulating cyclin D1 (CCND1) and ERα. Here, CCND1 is linked to breast carcinoma.